Services

Listings

• 

  Flavomycin [BSA]

  Immunology Shirley (New York) October 23, 2018 Check with publisher

  Flavomycin (bambermycins) is a performance enhancing antibiotic intended and available solely for use in animal nutrition. Its mechanism of action is to inhibit the synthesis of the bacterial wall. Flavomycin is predominately effective against gram-p...

• 

  HIR1 peptide

  Immunology Shirley (New York ) November 22, 2018 Check with publisher

  HIR1 is a member of the HIR complex that also contains HIR2, HIR3 and HPC2. This complex is responsible for the repression of histone gene transcription as well as having a role in nucleosome assembly.

• 

  RNA polymerase II CTD repeat YSPTSPS (phospho S2) peptide

  Immunology Shirley (New York) November 23, 2018 Check with publisher

  DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding ...

• 

  A4GNT/alpha4GNT peptide

  Immunology Shirley (New York) November 23, 2018 Check with publisher

  This gene encodes a protein from the glycosyltransferase 32 family. The enzyme catalyzes the transfer of N-acetylglucosamine (GlcNAc) to core 2 branched O-glycans. It forms a unique glycan, GlcNAcalpha1-->4Galbeta-->R and is largely associated ...

• 

  AAK1 peptide

  Immunology Shirley (New York ) November 23, 2018 Check with publisher

  Adaptor-related protein complex 2 (AP-2 complexes) functions during receptor-mediated endocytosis to trigger clathrin assembly, interact with membrane-bound receptors, and recruit encodytic accessory factors. This gene encodes a member of the SNF1 su...

• 

  Human ACSL4 blocking peptide

  Molecular Biology Shirley (New York ) November 23, 2018 Check with publisher

  The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain ...

• 

  Actin-like 7B peptide

  Immunology Shirley (New York) November 23, 2018 Check with publisher

  The protein encoded by this gene is a member of a family of actin-related proteins (ARPs) which share significant amino acid sequence identity to conventional actins. Both actins and ARPs have an actin fold, which is an ATP-binding cleft, as a common...

• 

  ADAM12 peptide

  Immunology Shirley (New York) November 23, 2018 Check with publisher

  This gene encodes a member of a family of proteins that are structurally related to snake venom disintegrins and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, musc...

• 

  Cholangiocarcinoma Vaccines

  Immunology Shirley (New York) November 29, 2018 Check with publisher

  Creative Biolabs is a world leader in the field of cancer vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best services for vaccine development against cholangiocarcinoma and guaran...

• 

  Tumor Cell Vaccines

  Immunology Shirley (New York) November 30, 2018 Check with publisher

  Cancer immunotherapy can be approached through the use of tumor cells as a platform to initiate a therapeutic immune response. Tumor cells by themselves are typically not immunogenic. However, as the science of determining how an effective APC initia...

• 

  Design and Modification of Allogeneic Cell Vaccines

  Molecular Biology Shirley (New York) November 30, 2018 Check with publisher

  Tumor cells are generally thought to be poorly immunogenic, although immunogenicity varies considerably between tumors of different backgrounds. Creative Biolabs is a world leader in the field of cancer vaccine development. We have a variety of strat...

• 

  IL-2-Secreting Tumor Cell Vaccines

  Immunology Shirley (New York) November 30, 2018 Check with publisher

  Cytokines have been used to treat advanced cancers, including renal cell carcinoma and melanoma with some success, but systemic administration is associated with marked toxicity. Recombinant cytokines expressed by modified tumor cells can be used to ...